Loading...
•
Oct 31, 2020
Phreesia Q3 2021 Earnings Report
Announced fiscal third quarter 2021 results with revenue increasing by 17% year-over-year.
Key Takeaways
Phreesia reported revenue of $38.5 million for the fiscal third quarter ended October 31, 2020, representing a 17% increase compared to the same period in the prior year. The average number of provider clients increased by 10% to 1,737, and the average revenue per provider client increased by 5% to $17,490. Adjusted EBITDA was positive $1.2 million. Cash and cash equivalents totaled $254.1 million.
Revenue was $38.5 million, up 17% year-over-year.
Average provider clients were 1,737, a 10% increase year-over-year.
Average revenue per provider client was $17,490, up 5% year-over-year.
Adjusted EBITDA was positive $1.2 million.
Phreesia
Phreesia
Phreesia Revenue by Segment
Revenue by Segment
Subscription Services Revenue
CapyFin.comPayment Processing Revenue
CapyFin.com Forward Guidance
For the full fiscal year 2021, ending January 31, 2021, the Company expects to report revenue of $146 to $147 million. For the full fiscal year 2022, ending January 31, 2022, the Company expects revenue to grow between 20 and 25 percent over fiscal year 2021.
Positive Outlook
- Revenue of $146 to $147 million expected for fiscal year 2021.
- Revenue growth of 20 to 25 percent expected for fiscal year 2022 over fiscal year 2021.
Challenges Ahead
- Uncertainty regarding the impact of the COVID-19 pandemic on business operations, financial performance, and results of operations.
- Potential impact from surges of COVID-19 cases and additional restrictions on patient visits.
- Disruptions to provider operations may impact subscription and related services revenue.
- Decline in non-essential and elective patient visits may impact revenue from payment processing tools.
- Decline in patient visits may impact revenue earned through patient engagement in life sciences.
Revenue & Expenses
Visualization of income flow from segment revenue to net income